Publications Scientifiques
-
Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis
Vierboom et al., Clin Exp Immunol. 2016Télécharger -
Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection
Ville et al, J Am Soc Nephrol 2016Télécharger -
Inducing CTLA-4-Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
Poirier et al, Science Transl Med 2010Télécharger -
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates
Watkins et al, JCI 2018Télécharger -
Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses
Zaitsu M. et al.; Journal of Clinical Investigation (2017)Télécharger -
Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection
Journal of the American Society of Nephrology (2016)Télécharger -
First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28
Poirier N. et al.; Journal of Immunology (Nov. 2016)Télécharger -
CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
Dillinger B. et al.; Frontiers in Immunology (2017)Télécharger